Abstract
Objective: 1) To find clinical value of cervical vestibular evoked myogenic potential (VEMP) in Ménière’s disease (MD). 2) To evaluate whether the VEMP results can be useful in assessing the stage of MD. 3) To evaluate the clinical effectiveness of VEMP in predicting hearing outcome. Method: The amplitude, peak latency and interaural amplitude difference ratio (IAD ratio) was obtained using cervical VEMP. The VEMP results of MD were compared with normal subjects and MD stages were compared with IAD ratio. Finally, the hearing changes were analyzed according to their VEMP results. Results: In clinically definite unilateral MD (n = 41), the prevalence of cervical VEMP abnormality in IAD ratio was 34.1%. Compared with healthy subjects (n = 33), the VEMP profile showed low amplitude and similar latency. The mean IAD ratio in MD was 23%, and was significantly different from healthy subjects ( P = .01). As the stage increased, IAD ratio was significantly increased ( P = .078). After stratification by initial hearing level, stage I and II subjects (hearing threshold, 0-40 dB) with abnormal IAD ratio showed a decrease in hearing over time compared to those with normal IAD ratio ( P = .065). Conclusion: VEMP parameters have an important clinical role in MD. Especially, IAD ratio can be used to assess the stage of MD. An abnormal IAD ratio may be used as a predictor of poor hearing outcomes in subjects with early stage MD.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.